Wednesday, July 27, 2016

BRIEF-Regulus says working to resolve issues outlined in letter from US FDA about clinical hold

* Received written communication from u.s. FDA outlining

information required to resolve clinical hold for its IND for

RG-101

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)